HPV vaccine 4-valent, 1 dose

General Description:
Human Papillomavirus vaccine, quadrivalent, types 6, 11, 16 and 18, recombinant virus like particle vaccine, 1 dose vial with VVM30.

Human Papillomavirus vaccine is indicated for use in females aged 9 to 26 years for the prevention of cervical, vulvar, and vaginal cancer, precancerous or dysplastic lesions, genital warts, and persistent infection caused by Human Papillomavirus Types, 6, 11, 16 and 18 (which are included in the vaccine).

The use of Human Papillomavirus vaccine should be based on official recommendations.

Immunization schedule:
Human Papillomavirus vaccine should be administered intramuscularly as 3 separate 0.5-ml doses according to the following schedule:

First dose: at elected time
Second dose: 2 months after the first dose
Third dose: 6 months after the first dose

Packaging, transport and storage:
Human Papillomavirus vaccine must be stored and transported between +2°C and +8°C.
Human Papillomavirus vaccine MUST NOT BE FROZEN.
The vaccine should be protected from light.

Available in cartons of one and ten 0.5ml single-dose vials, with VVM30. Cold chain volume 15cm3 per dose (carton of 10 vials), 75cm3 per dose (carton of 1 vial).

For more information

For information on product specifications, please see the WHO website on Prequalified Vaccines at
https://www.who.int/immunization_standards /vaccine_quality/PQ_179_HPV_Merck/en/
For more information on WHO’s recommendation for use of Human Papillomavirus vaccine, please see
https://www.who.int/immun ization/en/

Volume

Estimated volume:
15cm3 per dose for a carton of 10 vials
75cm3 per dose for a carton of 1 vial